Čeština 
Slovenčina 
Română 
Deutsch ZABCARE
Symptomatic treatment of urge incontinence in adults with overactive bladder
Zabcare 30 x 10 MG
Zabcare 100 x 10 MG
Zabcare 30 x 5 MG
Zabcare 100 x 5 MG
QUALITATIVE AND QUANTITATIVE COMPOSITION
Zabcare 5 mg: one film-coated tablet contains 5 mg solifenacin succinates equivalent to 3.8 mg solifenacin.
Zabcare 10 mg: one film-coated tablet contains 10 mg solifenacin succinates equivalent to 7.5 mg solifenacin.Excipients: lactose monohydrate 107.5 mg 102.5 mg
THERAPEUTIC INDICATIONS
Zabcare is indicated in adults for symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in patients with overactive bladder syndrome.
DISPENSING AND REIMBURSEMENT
Medicinal product is subjected to medical prescription. The medicinal product is covered by public health insurance.
Mandatory information
